The MS Australia Clinical Trials Network was established in 2010 to facilitate the clinical trials process for MS in Australia and New Zealand and increase awareness and access to clinical trials for people with MS and other demyelinating diseases. The MS Australia Clinical Trials Network is a central point of information for people interested in participating in or conducting a MS clinical trial and for news about MS clinical research and trial activity.
In 2023, the clinical trials network expanded its scope by listing trials in other demyelinating diseases, MOGAD and NMOSD, to foster a comprehensive understanding of this wider group of diseases.
MS Australia Clinical Trials Network does not aim to replace direct interaction between trial sponsors and neurologists or trial sites. Rather, it aims to increase the availability of information and maximise opportunities for participation for all parties.
The MS Australia Clinical Trials Network is administered by MS Australia. The Network’s Executive Committee consists of MS neurologist representatives from Australia and New Zealand, supported by a Scientific Review Committee.
"*" indicates required fields